Market Overview

UBS Maintains Neutral on Eli Lilly and Company, Raises PT to $51.00

Share:

Get News First. Profit Faster

upsell-button
With Benzinga Professional get unlimited access to ALL content! PLUS:
  • REALTIME NEWSFEED
  • REALTIME AUDIO NEWS
  • FULL CALENDAR SUITE
  • CHAT WITH OUR NEWS DESK

Latest Ratings for LLY

DateFirmActionFromTo
Nov 2016BMO CapitalDowngradesOutperformMarket Perform
Nov 2016Atlantic EquitiesDowngradesOverweightNeutral
Sep 2016Goldman SachsUpgradesNeutralBuy

View More Analyst Ratings for LLY
View the Latest Analyst Ratings

Posted-In: News Price Target Analyst Ratings

 

Related Articles (LLY)